Abstract:In this issue of the Journal , we read with interest the comprehensive review of the epigenetics of the oxytocin receptor gene ( OXTR ) by Nance and colleagues. 1 Oxytocin long has been understood to be involved in parturition and lactation through stimulation of uterine contractions 2 and milk expression. 3 Over the last few decades, rigorous studies have revealed its role in social behavior. 4 Given the critical importance of social behavior in a host of developmental outcomes, including neurodevelopmental disorders, this discovery has motivated further investigation into possible oxytocin-related biomarkers in brain development, as well as studies that have explored oxytocin as a possible therapeutic target for conditions, such as autism spectrum disorder (ASD) 5 and psychopathy. 6 To understand the role of oxytocin in social behavior, the study of epigenetics, as reviewed by Nance et al., is likely a very useful endeavor. Epigenetics refers to biologic modifications that alter gene expression and phenotype in the absence of changes to gene sequence. DNA methylation, in which a methyl group is added to a cytosine followed by guanine (CpG site), is among the most commonly studied epigenetic modifications. Classically, more highly methylated areas of DNA are less available to transcription factors, leading to less gene expression. 7 However, interpreting human epigenetic biomarkers is not straightforward.

Oxytocin receptor epigenetics: from biomarker to potential therapeutic target